| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $121,867 | $138,639 | $156,595 | $171,340 | $177,011 |
| Gross Profit | $112,914 | $127,744 | $143,560 | $154,047 | $157,261 |
| Operating Income | $6,360 | $7,489 | $8,452 | $8,499 | $7,862 |
| Net Income | $4,572 | $6,104 | $6,025 | $5,987 | $5,980 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $121,867 | $138,639 | $156,595 | $171,340 | $177,011 |
| Gross Profit | $112,914 | $127,744 | $143,560 | $154,047 | $157,261 |
| Operating Income | $6,360 | $7,489 | $8,452 | $8,499 | $7,862 |
| Net Income | $4,572 | $6,104 | $6,025 | $5,987 | $5,980 |
Over the five-year period, Elevance Health’s revenue has shown steady growth, rising from approximately $121.9 billion in 2020 to $177.0 billion in 2024. The company’s gross profit has followed a similar upward trajectory, increasing from about $112.9 billion to $157.3 billion. This consistent improvement in top-line performance indicates an ability to grow its overall business amidst the competitive healthcare landscape. The revenue growth rates, however, appear to moderate over time. For instance, while the jump between 2020 and 2021 was more pronounced, the increase from 2023 to 2024 was relatively modest at just over 3%, suggesting a possible stabilization in market conditions or a maturing growth phase. In contrast, operating income and net income reveal a more nuanced picture. Operating income rose steadily through 2022, peaking at around $8.5 billion, but then declined modestly to about $7.9 billion in 2024. Net income improved significantly from 2020 to 2021, increasing from $4.6 billion to $6.1 billion, but then has remained largely flat, fluctuating slightly around the $6.0 billion mark thereafter. No dramatic year-over-year swings exceeding a 20% change were observed, which implies operational adjustments and market responses were incremental rather than radical. Overall, Elevance Health appears to be financially sound, maintaining steady revenue and profitability growth with modest fluctuations in operating efficiency—reflecting a stable business model within a tightly regulated and competitive healthcare industry.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.